The Ets transcription factor ESE‐1 mediates induction of the COX‐2 gene by LPS in monocytes

Cyclooxygenase‐2 (COX‐2) is a key enzyme in the production of prostaglandins that are major inflammatory agents. COX‐2 production is triggered by exposure to various cytokines and to bacterial endotoxins. We present here a novel role for the Ets transcription factor ESE‐1 in regulating the COX‐2 gen...

Full description

Saved in:
Bibliographic Details
Published inThe FEBS journal Vol. 272; no. 7; pp. 1676 - 1687
Main Authors Grall, Franck T., Prall, Wolf C., Wei, Wanjiang, Gu, Xuesong, Cho, Je‐Yoel, Choy, Bob K., Zerbini, Luiz F., Inan, Mehmet S., Goldring, Steven R., Gravallese, Ellen M., Goldring, Mary B., Oettgen, Peter, Libermann, Towia A.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.04.2005
Blackwell Publishing Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cyclooxygenase‐2 (COX‐2) is a key enzyme in the production of prostaglandins that are major inflammatory agents. COX‐2 production is triggered by exposure to various cytokines and to bacterial endotoxins. We present here a novel role for the Ets transcription factor ESE‐1 in regulating the COX‐2 gene in response to endotoxin and other pro‐inflammatory stimuli. We report that the induction of COX‐2 expression by lipopolysaccharide (LPS) and pro‐inflammatory cytokines correlates with ESE‐1 induction in monocyte/macrophages. ESE‐1, in turn, binds to several E26 transformation specific (Ets) sites on the COX‐2 promoter. In vitro analysis demonstrates that ESE‐1 binds to and activates the COX‐2 promoter to levels comparable to LPS‐mediated induction. Moreover, we provide results showing that the induction of COX‐2 by LPS may require ESE‐1, as the mutation of the Ets sites in the COX‐2 promoter or overexpression of a dominant‐negative form of ESE‐1 inhibits LPS‐mediated COX‐2 induction. The effect of ESE‐1 on the COX‐2 promoter is further enhanced by cooperation with other transcription factors such as nuclear factor‐κB and nuclear factor of activated T cells. Neutralization of COX‐2 is the goal of many anti‐inflammatory drugs. As an activator of COX‐2 induction, ESE‐1 may become a target for such therapeutics as well. Together with our previous reports of the role of ESE‐1 as an inducer of nitric oxide synthase in endothelial cells and as a mediator of pro‐inflammatory cytokines in vascular and connective tissue cells, these results establish ESE‐1 as an important player in the regulation of inflammation.
AbstractList Cyclooxygenase‐2 (COX‐2) is a key enzyme in the production of prostaglandins that are major inflammatory agents. COX‐2 production is triggered by exposure to various cytokines and to bacterial endotoxins. We present here a novel role for the Ets transcription factor ESE‐1 in regulating the COX‐2 gene in response to endotoxin and other pro‐inflammatory stimuli. We report that the induction of COX‐2 expression by lipopolysaccharide (LPS) and pro‐inflammatory cytokines correlates with ESE‐1 induction in monocyte/macrophages. ESE‐1, in turn, binds to several E26 transformation specific (Ets) sites on the COX‐2 promoter. In vitro analysis demonstrates that ESE‐1 binds to and activates the COX‐2 promoter to levels comparable to LPS‐mediated induction. Moreover, we provide results showing that the induction of COX‐2 by LPS may require ESE‐1, as the mutation of the Ets sites in the COX‐2 promoter or overexpression of a dominant‐negative form of ESE‐1 inhibits LPS‐mediated COX‐2 induction. The effect of ESE‐1 on the COX‐2 promoter is further enhanced by cooperation with other transcription factors such as nuclear factor‐κB and nuclear factor of activated T cells. Neutralization of COX‐2 is the goal of many anti‐inflammatory drugs. As an activator of COX‐2 induction, ESE‐1 may become a target for such therapeutics as well. Together with our previous reports of the role of ESE‐1 as an inducer of nitric oxide synthase in endothelial cells and as a mediator of pro‐inflammatory cytokines in vascular and connective tissue cells, these results establish ESE‐1 as an important player in the regulation of inflammation.
Cyclooxygenase-2 (COX-2) is a key enzyme in the production of prostaglandins that are major inflammatory agents. COX-2 production is triggered by exposure to various cytokines and to bacterial endotoxins. We present here a novel role for the Ets transcription factor ESE-1 in regulating the COX-2 gene in response to endotoxin and other pro-inflammatory stimuli. We report that the induction of COX-2 expression by lipopolysaccharide (LPS) and pro-inflammatory cytokines correlates with ESE-1 induction in monocyte-macrophages. ESE-1, in turn, binds to several E26 transformation specific (Ets) sites on the COX-2 promoter. In vitro analysis demonstrates that ESE-1 binds to and activates the COX-2 promoter to levels comparable to LPS-mediated induction. Moreover, we provide results showing that the induction of COX-2 by LPS may require ESE-1, as the mutation of the Ets sites in the COX-2 promoter or overexpression of a dominant-negative form of ESE-1 inhibits LPS-mediated COX-2 induction. The effect of ESE-1 on the COX-2 promoter is further enhanced by cooperation with other transcription factors such as nuclear factor- Kappa B and nuclear factor of activated T cells. Neutralization of COX-2 is the goal of many anti-inflammatory drugs. As an activator of COX-2 induction, ESE-1 may become a target for such therapeutics as well. Together with our previous reports of the role of ESE-1 as an inducer of nitric oxide synthase in endothelial cells and as a mediator of pro-inflammatory cytokines in vascular and connective tissue cells, these results establish ESE-1 as an important player in the regulation of inflammation.
Cyclooxygenase-2 (COX-2) is a key enzyme in the production of prostaglandins that are major inflammatory agents. COX-2 production is triggered by exposure to various cytokines and to bacterial endotoxins. We present here a novel role for the Ets transcription factor ESE-1 in regulating the COX-2 gene in response to endotoxin and other pro-inflammatory stimuli. We report that the induction of COX-2 expression by lipopolysaccharide (LPS) and pro-inflammatory cytokines correlates with ESE-1 induction in monocyte/macrophages. ESE-1, in turn, binds to several E26 transformation specific (Ets) sites on the COX-2 promoter. In vitro analysis demonstrates that ESE-1 binds to and activates the COX-2 promoter to levels comparable to LPS-mediated induction. Moreover, we provide results showing that the induction of COX-2 by LPS may require ESE-1, as the mutation of the Ets sites in the COX-2 promoter or overexpression of a dominant-negative form of ESE-1 inhibits LPS-mediated COX-2 induction. The effect of ESE-1 on the COX-2 promoter is further enhanced by cooperation with other transcription factors such as nuclear factor-kappaB and nuclear factor of activated T cells. Neutralization of COX-2 is the goal of many anti-inflammatory drugs. As an activator of COX-2 induction, ESE-1 may become a target for such therapeutics as well. Together with our previous reports of the role of ESE-1 as an inducer of nitric oxide synthase in endothelial cells and as a mediator of pro-inflammatory cytokines in vascular and connective tissue cells, these results establish ESE-1 as an important player in the regulation of inflammation. [PUBLICATION ABSTRACT]
Cyclooxygenase‐2 (COX‐2) is a key enzyme in the production of prostaglandins that are major inflammatory agents. COX‐2 production is triggered by exposure to various cytokines and to bacterial endotoxins. We present here a novel role for the Ets transcription factor ESE‐1 in regulating the COX‐2 gene in response to endotoxin and other pro‐inflammatory stimuli. We report that the induction of COX‐2 expression by lipopolysaccharide (LPS) and pro‐inflammatory cytokines correlates with ESE‐1 induction in monocyte/macrophages. ESE‐1, in turn, binds to several E26 transformation specific (Ets) sites on the COX‐2 promoter. In vitro analysis demonstrates that ESE‐1 binds to and activates the COX‐2 promoter to levels comparable to LPS‐mediated induction. Moreover, we provide results showing that the induction of COX‐2 by LPS may require ESE‐1, as the mutation of the Ets sites in the COX‐2 promoter or overexpression of a dominant‐negative form of ESE‐1 inhibits LPS‐mediated COX‐2 induction. The effect of ESE‐1 on the COX‐2 promoter is further enhanced by cooperation with other transcription factors such as nuclear factor‐κB and nuclear factor of activated T cells. Neutralization of COX‐2 is the goal of many anti‐inflammatory drugs. As an activator of COX‐2 induction, ESE‐1 may become a target for such therapeutics as well. Together with our previous reports of the role of ESE‐1 as an inducer of nitric oxide synthase in endothelial cells and as a mediator of pro‐inflammatory cytokines in vascular and connective tissue cells, these results establish ESE‐1 as an important player in the regulation of inflammation.
Author Prall, Wolf C.
Inan, Mehmet S.
Choy, Bob K.
Oettgen, Peter
Gu, Xuesong
Goldring, Mary B.
Wei, Wanjiang
Grall, Franck T.
Libermann, Towia A.
Gravallese, Ellen M.
Cho, Je‐Yoel
Zerbini, Luiz F.
Goldring, Steven R.
Author_xml – sequence: 1
  givenname: Franck T.
  surname: Grall
  fullname: Grall, Franck T.
– sequence: 2
  givenname: Wolf C.
  surname: Prall
  fullname: Prall, Wolf C.
– sequence: 3
  givenname: Wanjiang
  surname: Wei
  fullname: Wei, Wanjiang
– sequence: 4
  givenname: Xuesong
  surname: Gu
  fullname: Gu, Xuesong
– sequence: 5
  givenname: Je‐Yoel
  surname: Cho
  fullname: Cho, Je‐Yoel
– sequence: 6
  givenname: Bob K.
  surname: Choy
  fullname: Choy, Bob K.
– sequence: 7
  givenname: Luiz F.
  surname: Zerbini
  fullname: Zerbini, Luiz F.
– sequence: 8
  givenname: Mehmet S.
  surname: Inan
  fullname: Inan, Mehmet S.
– sequence: 9
  givenname: Steven R.
  surname: Goldring
  fullname: Goldring, Steven R.
– sequence: 10
  givenname: Ellen M.
  surname: Gravallese
  fullname: Gravallese, Ellen M.
– sequence: 11
  givenname: Mary B.
  surname: Goldring
  fullname: Goldring, Mary B.
– sequence: 12
  givenname: Peter
  surname: Oettgen
  fullname: Oettgen, Peter
– sequence: 13
  givenname: Towia A.
  surname: Libermann
  fullname: Libermann, Towia A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15794755$$D View this record in MEDLINE/PubMed
BookMark eNqNkUFr2zAYhsVoWZp2f2GIHXaLK8mSJV0GXXC2QqCFtJCbkGV5c0ikVLJpc-tP6G_cL5nchBZ6aXXRB3reFz49Y3DkvLMAQIwynM75KsOckgktmMgIQixDlEmSPXwCJy8PRy8zXY7AOMYVQjmjUn4GI8y4pJyxE6Bu_lpYdhF2QbtoQrvtWu9go03nAywX5b_HJww3tm51ZyNsXd2bZ8I3sEvR6dUyEQT-sc7Cagfn14sEwY133uxS4gwcN3od7ZfDfQpuZ-XN9PdkfvXrcnoxnxhKCjIxWuqG5kZTW1eiYoKbGssKSU0xx6wWqBbEIC45R9IWMrdCSILrRuS1JZTnp-D7vncb_F1vY6c2bTR2vdbO-j6qIm1LhRTvgpjnjEiME_jtDbjyfXBpCUUQxYjxYmgTe8gEH2OwjdqGdqPDTmGkBlVqpQYLajCiBlXqWZV6SNGvh_6-Sv_7Gjy4ScCPPXDfru3uw8VqVv5cDGP-H8fko-c
CitedBy_id crossref_primary_10_1097_MCD_0b013e328274264b
crossref_primary_10_1113_JP272240
crossref_primary_10_1038_s41419_020_2598_6
crossref_primary_10_3390_cells12020235
crossref_primary_10_1007_s12263_011_0244_8
crossref_primary_10_1007_s12038_023_00373_z
crossref_primary_10_1111_j_1468_2982_2008_01667_x
crossref_primary_10_1038_ajh_2010_164
crossref_primary_10_1080_08820139_2022_2084409
crossref_primary_10_1530_ERC_13_0450
crossref_primary_10_1038_s41598_018_24695_3
crossref_primary_10_1042_BCJ20160019
crossref_primary_10_1016_j_jsbmb_2016_05_006
crossref_primary_10_1039_D3FO03793B
crossref_primary_10_1186_2045_3701_4_76
crossref_primary_10_3390_cancers10120520
crossref_primary_10_1097_SHK_0b013e3181a5a377
crossref_primary_10_1016_j_dci_2009_05_003
crossref_primary_10_1186_s13578_016_0105_7
crossref_primary_10_3390_cells8070734
crossref_primary_10_1002_art_37806
crossref_primary_10_1016_j_canlet_2015_09_022
crossref_primary_10_4049_jimmunol_1101967
crossref_primary_10_1016_j_bbamcr_2007_09_001
crossref_primary_10_1152_ajplung_00513_2005
crossref_primary_10_1074_jbc_M111_265744
crossref_primary_10_1152_ajplung_00130_2007
crossref_primary_10_1158_0008_5472_CAN_12_4537
crossref_primary_10_1007_s11064_016_1990_1
crossref_primary_10_1038_labinvest_2011_186
crossref_primary_10_3724_abbs_2022020
crossref_primary_10_1155_2020_2308520
crossref_primary_10_1074_jbc_M109_050757
crossref_primary_10_4103_1673_5374_249232
crossref_primary_10_1161_01_RES_0000251056_85990_db
crossref_primary_10_1128_MCB_01530_07
crossref_primary_10_1016_j_jmb_2010_01_017
crossref_primary_10_1074_jbc_M702309200
crossref_primary_10_1111_jdv_12027
crossref_primary_10_1016_j_jep_2011_09_011
crossref_primary_10_1080_03008207_2016_1200566
crossref_primary_10_1002_jcp_21338
crossref_primary_10_1371_journal_pone_0034561
crossref_primary_10_1016_j_ydbio_2013_06_019
crossref_primary_10_1074_jbc_M609907200
Cites_doi 10.4049/jimmunol.163.2.963
10.1002/jcp.1112
10.1096/fasebj.12.14.1541
10.1046/j.1432-1033.2000.01778.x
10.1074/jbc.M302076200
10.1128/MCB.17.8.4419
10.1177/107327489800500103
10.1002/art.10942
10.2106/00004623-198365050-00001
10.1016/S0014-5793(01)02422-X
10.1002/(SICI)1097-0142(19960501)77:9<1862::AID-CNCR16>3.0.CO;2-Y
10.1093/molehr/6.6.561
10.3109/03008209709160231
10.1016/S0140-6736(99)12031-2
10.1159/000468614
10.1038/sj.onc.1200978
10.1002/art.1780400207
10.1006/geno.1997.4974
10.1172/JCI117595
10.1359/jbmr.2000.15.6.1138
10.1038/sj.onc.1201427
10.1074/jbc.M306267200
10.1074/jbc.270.42.24965
10.1242/jcs.112.24.4695
10.1074/jbc.272.49.31065
10.1074/jbc.275.9.6259
10.1074/jbc.273.1.110
10.1038/sj.onc.1205503
10.1074/jbc.M308136200
10.1074/jbc.M006507200
10.1038/sj.onc.1202198
10.1038/sj.onc.1201111
10.1002/j.1460-2075.1991.tb08053.x
10.1074/jbc.M001381200
10.1074/jbc.M010692200
10.1093/nar/25.21.4287
10.1074/jbc.M111415200
10.1074/jbc.271.42.26007
10.1074/jbc.M005077200
10.1002/j.1460-2075.1990.tb07394.x
10.1074/jbc.M106865200
ContentType Journal Article
Copyright 2005 FEBS
Copyright_xml – notice: 2005 FEBS
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7QP
7QR
7TK
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7T5
7X8
DOI 10.1111/j.1742-4658.2005.04592.x
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
Technology Research Database
Nucleic Acids Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Genetics Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList
AIDS and Cancer Research Abstracts
MEDLINE - Academic
Virology and AIDS Abstracts
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1742-4658
EndPage 1687
ExternalDocumentID 824491331
10_1111_j_1742_4658_2005_04592_x
15794755
FEBS4592
Genre article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
Feature
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01/AI49527
– fundername: NCI NIH HHS
  grantid: KO8/CA 71429
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
24P
29H
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHBH
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEFU
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C1A
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EAD
EAP
EAS
EAU
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EST
ESTFP
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HH5
HZI
HZ~
IHE
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OBS
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RNS
ROL
RX1
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
W8V
W99
WBFHL
WBKPD
WIH
WIJ
WIK
WIN
WOHZO
WOQ
WOW
WQJ
WRC
WXI
WXSBR
WYISQ
X7M
XG1
Y6R
~IA
~KM
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7QP
7QR
7TK
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7T5
7X8
ID FETCH-LOGICAL-c4262-ca9af43ca4edb8b587cd19b09a41715d80d82c0797709e693e88921df83de2473
IEDL.DBID DR2
ISSN 1742-464X
IngestDate Fri Aug 16 22:40:49 EDT 2024
Fri Aug 16 22:01:48 EDT 2024
Thu Oct 10 22:11:34 EDT 2024
Fri Aug 23 02:25:44 EDT 2024
Sat Sep 28 07:45:11 EDT 2024
Sat Aug 24 00:58:03 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4262-ca9af43ca4edb8b587cd19b09a41715d80d82c0797709e693e88921df83de2473
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 15794755
PQID 204105768
PQPubID 28478
PageCount 12
ParticipantIDs proquest_miscellaneous_67554898
proquest_miscellaneous_17352911
proquest_journals_204105768
crossref_primary_10_1111_j_1742_4658_2005_04592_x
pubmed_primary_15794755
wiley_primary_10_1111_j_1742_4658_2005_04592_x_FEBS4592
PublicationCentury 2000
PublicationDate April 2005
2005-Apr
2005-04-00
20050401
PublicationDateYYYYMMDD 2005-04-01
PublicationDate_xml – month: 04
  year: 2005
  text: April 2005
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
– name: Oxford
PublicationTitle The FEBS journal
PublicationTitleAlternate FEBS J
PublicationYear 2005
Publisher Blackwell Science Ltd
Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Science Ltd
– name: Blackwell Publishing Ltd
References 2001; 188
1997; 40
2000; 355
2000; 6
1997; 272
1991; 10
1997; 25
2002; 277
1997; 45
1999; 163
2000; 275
2003; 278
1995; 270
1998; 273
1996; 77
2001; 276
2001; 496
1998; 17
2004; 279
2000; 267
2000; 15
1997; 15
1997; 14
1997; 36
2002; 21
1983; 65
1996; 271
2003; 48
1997; 17
1999; 112
1996; 49
1998; 5
1990; 9
1994; 94
1998; 12
e_1_2_23_18_2
e_1_2_23_17_2
e_1_2_23_39_2
e_1_2_23_16_2
e_1_2_23_38_2
e_1_2_23_15_2
e_1_2_23_37_2
e_1_2_23_19_2
e_1_2_23_21_2
e_1_2_23_20_2
e_1_2_23_2_2
e_1_2_23_25_2
e_1_2_23_40_2
e_1_2_23_3_2
e_1_2_23_24_2
e_1_2_23_41_2
e_1_2_23_4_2
e_1_2_23_23_2
e_1_2_23_42_2
e_1_2_23_5_2
e_1_2_23_22_2
e_1_2_23_6_2
e_1_2_23_29_2
e_1_2_23_7_2
e_1_2_23_28_2
e_1_2_23_8_2
e_1_2_23_27_2
e_1_2_23_9_2
e_1_2_23_26_2
e_1_2_23_32_2
e_1_2_23_10_2
e_1_2_23_31_2
e_1_2_23_30_2
e_1_2_23_13_2
e_1_2_23_36_2
e_1_2_23_14_2
e_1_2_23_35_2
e_1_2_23_11_2
e_1_2_23_34_2
e_1_2_23_12_2
e_1_2_23_33_2
References_xml – volume: 17
  start-page: 4419
  year: 1997
  end-page: 4433
  article-title: Isolation and characterization of a novel epithelium‐specific transcription factor, ESE‐1, a member of the ets family
  publication-title: Mol Cell Biol
– volume: 112
  start-page: 4695
  year: 1999
  end-page: 4703
  article-title: Characterisation of the tumour necrosis factor (TNF)‐(alpha) response elements in the human ICAM‐2 promoter
  publication-title: J Cell Sci
– volume: 277
  start-page: 18649
  year: 2002
  end-page: 18657
  article-title: Cyclooxygenase‐2 is overexpressed in her‐2/neu‐positive breast cancer. Evidence for involvement of AP‐1 and PEA3
  publication-title: J Biol Chem
– volume: 49
  start-page: 20
  year: 1996
  end-page: 37
  article-title: Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells
  publication-title: Enzyme Protein
– volume: 21
  start-page: 3934
  year: 2002
  end-page: 3938
  article-title: ErbB2 activation of ESX gene expression
  publication-title: Oncogene
– volume: 14
  start-page: 2651
  year: 1997
  end-page: 2660
  article-title: Differential regulation of interstitial collagenase (MMP‐1) gene expression by ETS transcription factors
  publication-title: Oncogene
– volume: 65
  start-page: 575
  year: 1983
  end-page: 584
  article-title: The synovial‐like membrane at the bone–cement interface in loose total hip replacements and its proposed role in bone lysis
  publication-title: J Bone Joint Surg Am
– volume: 15
  start-page: 1138
  year: 2000
  end-page: 1146
  article-title: Involvement of CCAAT enhancer binding protein transcription factors in the regulation of prostaglandin G/H synthase 2 expression by interleukin‐1 in osteoblastic MC3T3–E1 cells
  publication-title: J Bone Miner Res
– volume: 273
  start-page: 110
  year: 1998
  end-page: 117
  article-title: A novel ets‐related transcription factor, ERT/ESX/ESE‐1, regulates expression of the transforming growth factor‐beta type II receptor
  publication-title: J Biol Chem
– volume: 14
  start-page: 1617
  year: 1997
  end-page: 1622
  article-title: ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis
  publication-title: Oncogene
– volume: 267
  start-page: 6798
  year: 2000
  end-page: 6809
  article-title: Critical role of C/EBPdelta and C/EBPbeta factors in the stimulation of the cyclooxygenase‐2 gene transcription by interleukin‐1beta in articular chondrocytes
  publication-title: Eur J Biochem
– volume: 163
  start-page: 963
  year: 1999
  end-page: 969
  article-title: Lipopolysaccharide modulates cyclooxygenase‐2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL‐1 beta and TNF‐alpha
  publication-title: J Immunol
– volume: 270
  start-page: 24965
  year: 1995
  end-page: 24971
  article-title: Transcriptional regulation of human prostaglandin‐endoperoxide synthase‐2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin‐6 expression site and cAMP response element
  publication-title: J Biol Chem
– volume: 275
  start-page: 23627
  year: 2000
  end-page: 23635
  article-title: An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase‐2 gene in human T lymphocytes
  publication-title: J Biol Chem
– volume: 276
  start-page: 3302
  year: 2001
  end-page: 3309
  article-title: ESE‐1 is a novel transcriptional mediator of inflammation that interacts with NF‐kappa B to regulate the inducible nitric‐oxide synthase gene
  publication-title: J Biol Chem
– volume: 355
  start-page: 646
  year: 2000
  end-page: 648
  article-title: COX‐1, COX‐2, and COX‐3 and the future treatment of chronic inflammatory disease
  publication-title: Lancet
– volume: 276
  start-page: 3977
  year: 2001
  end-page: 3982
  article-title: Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase‐2 gene expression in endotoxin‐treated macrophage/monocytic cells
  publication-title: J Biol Chem
– volume: 278
  start-page: 22563
  year: 2003
  end-page: 22573
  article-title: Myeloid differentiation factor 88‐dependent transcriptional regulation of cyclooxygenase‐2 expression by CpG DNA: role of NF‐kappaB and p38
  publication-title: J Biol Chem
– volume: 496
  start-page: 147
  year: 2001
  end-page: 151
  article-title: Overlapping CRE and E‐box promoter elements can independently regulate COX‐2 gene transcription in macrophages
  publication-title: FEBS Lett
– volume: 6
  start-page: 561
  year: 2000
  end-page: 565
  article-title: NF‐kappaB and AP‐1 are required for cyclo‐oxygenase 2 gene expression in amnion epithelial cell line (WISH)
  publication-title: Mol Hum Reprod
– volume: 45
  start-page: 456
  year: 1997
  end-page: 457
  article-title: The novel epithelial‐specific Ets transcription factor gene ESX maps to human chromosome 1q32.1
  publication-title: Genomics
– volume: 276
  start-page: 20108
  year: 2001
  end-page: 20115
  article-title: PEA3 is up‐regulated in response to Wnt1 and activates the expression of cyclooxygenase‐2
  publication-title: J Biol Chem
– volume: 36
  start-page: 321
  year: 1997
  end-page: 335
  article-title: ETS sites in the promoters of the matrix metalloproteinases collagenase (MMP‐1) and stromelysin (MMP‐3) are auxiliary elements that regulate basal and phorbol‐induced transcription
  publication-title: Connect Tissue Res
– volume: 279
  start-page: 6658
  year: 2004
  end-page: 6665
  article-title: Transcriptional regulation of the cyclooxygenase‐2 gene in macrophages by PU.1
  publication-title: J Biol Chem
– volume: 40
  start-page: 226
  year: 1997
  end-page: 236
  article-title: Involvement of nuclear factor kappa B in the regulation of cyclooxygenase‐2 expression by interleukin‐1 in rheumatoid synoviocytes
  publication-title: Arthritis Rheum
– volume: 77
  start-page: 1862
  year: 1996
  end-page: 1872
  article-title: In vitro modulation of tumor progression‐associated properties of hormone refractory prostate carcinoma cell lines by cytokines
  publication-title: Cancer
– volume: 17
  start-page: 2719
  year: 1998
  end-page: 2732
  article-title: A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13–15, a region subject to LOH and rearrangement in human carcinoma cell lines
  publication-title: Oncogene
– volume: 9
  start-page: 2241
  year: 1990
  end-page: 2246
  article-title: The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites
  publication-title: EMBO J
– volume: 272
  start-page: 31065
  year: 1997
  end-page: 31072
  article-title: Tumor necrosis factor‐alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase‐2 expression and prostaglandin E2 synthesis
  publication-title: J Biol Chem
– volume: 94
  start-page: 2307
  year: 1994
  end-page: 2316
  article-title: Interleukin‐1 beta‐modulated gene expression in immortalized human chondrocytes
  publication-title: J Clin Invest
– volume: 15
  start-page: 2449
  year: 1997
  end-page: 2462
  article-title: A novel epithelial‐expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer
  publication-title: Oncogene
– volume: 25
  start-page: 4287
  year: 1997
  end-page: 4295
  article-title: The expression of a novel, epithelium‐specific ets transcription factor is restricted to the most differentiated layers in the epidermis
  publication-title: Nucleic Acids Res
– volume: 12
  start-page: 1541
  year: 1998
  end-page: 1550
  article-title: The epithelium‐specific ets transcription factor ESX is associated with mammary gland development and involution
  publication-title: FASEB J
– volume: 188
  start-page: 243
  year: 2001
  end-page: 252
  article-title: Role of transcription factor Ets‐1 in the apoptosis of human vascular endothelial cells
  publication-title: J Cell Physiol
– volume: 5
  start-page: 25
  year: 1998
  end-page: 33
  article-title: Large granular lymphocyte leukemia
  publication-title: Cancer Control
– volume: 271
  start-page: 26007
  year: 1996
  end-page: 26012
  article-title: ELF‐1 interacts with and transactivates the IgH enhancer pi site
  publication-title: J Biol Chem
– volume: 279
  start-page: 18694
  year: 2004
  end-page: 18700
  article-title: Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase‐2 by nitric oxide in colorectal cancer cells
  publication-title: J Biol Chem
– volume: 276
  start-page: 40769
  year: 2001
  end-page: 40777
  article-title: The transcription factor C/EBPbeta is essential for inducible expression of the cox‐2 gene in macrophages but not in fibroblasts
  publication-title: J Biol Chem
– volume: 275
  start-page: 6259
  year: 2000
  end-page: 6266
  article-title: Transcriptional activation of the cyclooxygenase‐2 gene in endotoxin‐treated RAW 264.7 macrophages
  publication-title: J Biol Chem
– volume: 48
  start-page: 1249
  year: 2003
  end-page: 1260
  article-title: Responses to the proinflammatory cytokines interleukin‐1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB‐mediated induction of the Ets transcription factor ESE‐1
  publication-title: Arthritis Rheum
– volume: 10
  start-page: 1127
  year: 1991
  end-page: 1134
  article-title: The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins
  publication-title: EMBO J
– ident: e_1_2_23_4_2
  doi: 10.4049/jimmunol.163.2.963
– ident: e_1_2_23_16_2
  doi: 10.1002/jcp.1112
– ident: e_1_2_23_31_2
  doi: 10.1096/fasebj.12.14.1541
– ident: e_1_2_23_11_2
  doi: 10.1046/j.1432-1033.2000.01778.x
– ident: e_1_2_23_15_2
  doi: 10.1074/jbc.M302076200
– ident: e_1_2_23_24_2
  doi: 10.1128/MCB.17.8.4419
– ident: e_1_2_23_28_2
  doi: 10.1177/107327489800500103
– ident: e_1_2_23_22_2
  doi: 10.1002/art.10942
– ident: e_1_2_23_39_2
  doi: 10.2106/00004623-198365050-00001
– ident: e_1_2_23_13_2
  doi: 10.1016/S0014-5793(01)02422-X
– ident: e_1_2_23_42_2
  doi: 10.1002/(SICI)1097-0142(19960501)77:9<1862::AID-CNCR16>3.0.CO;2-Y
– ident: e_1_2_23_8_2
  doi: 10.1093/molehr/6.6.561
– ident: e_1_2_23_34_2
  doi: 10.3109/03008209709160231
– ident: e_1_2_23_5_2
  doi: 10.1016/S0140-6736(99)12031-2
– ident: e_1_2_23_2_2
  doi: 10.1159/000468614
– ident: e_1_2_23_29_2
  doi: 10.1038/sj.onc.1200978
– ident: e_1_2_23_12_2
  doi: 10.1002/art.1780400207
– ident: e_1_2_23_40_2
  doi: 10.1006/geno.1997.4974
– ident: e_1_2_23_38_2
  doi: 10.1172/JCI117595
– ident: e_1_2_23_6_2
  doi: 10.1359/jbmr.2000.15.6.1138
– ident: e_1_2_23_25_2
  doi: 10.1038/sj.onc.1201427
– ident: e_1_2_23_20_2
  doi: 10.1074/jbc.M306267200
– ident: e_1_2_23_27_2
  doi: 10.1074/jbc.270.42.24965
– ident: e_1_2_23_37_2
  doi: 10.1242/jcs.112.24.4695
– ident: e_1_2_23_3_2
  doi: 10.1074/jbc.272.49.31065
– ident: e_1_2_23_10_2
  doi: 10.1074/jbc.275.9.6259
– ident: e_1_2_23_30_2
  doi: 10.1074/jbc.273.1.110
– ident: e_1_2_23_32_2
  doi: 10.1038/sj.onc.1205503
– ident: e_1_2_23_19_2
  doi: 10.1074/jbc.M308136200
– ident: e_1_2_23_21_2
  doi: 10.1074/jbc.M006507200
– ident: e_1_2_23_26_2
  doi: 10.1038/sj.onc.1202198
– ident: e_1_2_23_33_2
  doi: 10.1038/sj.onc.1201111
– ident: e_1_2_23_36_2
  doi: 10.1002/j.1460-2075.1991.tb08053.x
– ident: e_1_2_23_7_2
  doi: 10.1074/jbc.M001381200
– ident: e_1_2_23_17_2
  doi: 10.1074/jbc.M010692200
– ident: e_1_2_23_23_2
  doi: 10.1093/nar/25.21.4287
– ident: e_1_2_23_18_2
  doi: 10.1074/jbc.M111415200
– ident: e_1_2_23_41_2
  doi: 10.1074/jbc.271.42.26007
– ident: e_1_2_23_14_2
  doi: 10.1074/jbc.M005077200
– ident: e_1_2_23_35_2
  doi: 10.1002/j.1460-2075.1990.tb07394.x
– ident: e_1_2_23_9_2
  doi: 10.1074/jbc.M106865200
SSID ssj0035499
Score 2.0822928
Snippet Cyclooxygenase‐2 (COX‐2) is a key enzyme in the production of prostaglandins that are major inflammatory agents. COX‐2 production is triggered by exposure to...
Cyclooxygenase-2 (COX-2) is a key enzyme in the production of prostaglandins that are major inflammatory agents. COX-2 production is triggered by exposure to...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 1676
SubjectTerms Animals
Base Sequence
COX‐2
Cyclooxygenase 2
Cytokines
DNA-Binding Proteins - genetics
DNA-Binding Proteins - metabolism
Enzyme Induction - physiology
Enzymes
ESE‐1
Ets
Gene expression
Humans
Immune system
Lipopolysaccharides - metabolism
LPS
Membrane Proteins
Mice
Molecular Sequence Data
Monocytes - metabolism
Mutation
NFATC Transcription Factors
Nitric oxide
Nuclear Proteins - metabolism
Promoter Regions, Genetic
Prostaglandin-Endoperoxide Synthases - biosynthesis
Prostaglandin-Endoperoxide Synthases - genetics
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins c-ets
Transcription Factors - genetics
Transcription Factors - metabolism
Title The Ets transcription factor ESE‐1 mediates induction of the COX‐2 gene by LPS in monocytes
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1742-4658.2005.04592.x
https://www.ncbi.nlm.nih.gov/pubmed/15794755
https://www.proquest.com/docview/204105768
https://search.proquest.com/docview/17352911
https://search.proquest.com/docview/67554898
Volume 272
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LjtMwFL1Cs4ENjxkeZWDwArFLlYedxMuhSjVCvEQZqbsojh0JjUgRTSXKik_gG_kSznWSQgeQEGIXKb5W4tzre45zfUz0GEmpNlnIRQzSBdJmVaDhJpgMFcBIlmjrtfRevEzPzuWzpVoO9U-8F6bXh9gtuHFk-PmaA7wy6_0gB60LJFLosDQilY6njCdZV4_x0ZudklTCNKjfG8kmcnm5qOc3He1nql_g5z6a9elofoMuxhfpq1AuppvOTOvPlzQe_8-b3qTrA2oVp72b3aIrrj2ko9MWjP39VjwRvo7UL9Af0tXZeIbcEZXwQlF0a9FxShwnKNEf8iOKRfHty9dI-N0rgLziXWt7MVuxagSQqZi9WqJFLODlTpiteP56gUYCobOqt7C4Tefz4u3sLBiOdAhqlr4P6kpXDdyjks6a3Kg8q22kTagrGWWRsnlo87gOM6DSULtUJy7PdRzZJk-si2WW3KGDdtW6eyQQAmmqGuVAsmUTM5VPlTESljBK6wlF4-crP_TKHeVPjAcjWvKI8jmcqvQjWn6a0PH4ncshltdowKWwoGUTerS7i3HkPytV61abNXoDjkXa-HML8DJwQ40-7vbu8-OZFKZE3J1Q5p3grx-2nBdPF3x5_58tj-mal6L1lUgP6KD7uHEPAbI6c-LD54QTnfoOkY0Xyg
link.rule.ids 315,786,790,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB2hcigXCi0fS4H6gLhllQ87iY9lyWqBbUFsK-3NSmJHqoBsxWYllhM_gd_IL-HZSRa2gIQQt0jxWLYzz_PGGc8QPYFRKovEt0EM3HhcJ7knoSbYDAXISBJJ7XLpnZzGk3P-ci7mXTkgexemzQ-xOXCzyHD7tQW4PZDeRjn8Oo_DhnZnI1zIcAhCeR3oFxalz99ucklF1hFqb0daGT6_Gtbzm562bdUvBHSbzzqDNN6j9_1U2jiUd8NVUwzLz1eyPP6nud6imx1xZcetpt2ma6bep4PjGk77hzV7ylwoqTuj36fdUV9G7oAUFJFlzZI11ir2exRr6_ywbJZ9-_I1YO4CC1gvu6h1m8-WLSoGcspGr-doETIoumHFmk3fzNCIAT2Lcg2JO3Q-zs5GE6-r6uCVNvu9V-Yyr6AhOTe6SAuRJqUOZOHLnAdJIHTq6zQs_QTE1JcmlpFJUxkGukojbUKeRHdpp17U5j4xoCCORSUM_Gxehdabj0VRcEhCKC4HFPTfT122yTvUT04PVlTZFbWlOIVyK6o-Deiw_9Cqg_MSDWw0LDyzAR1t3mId7c-VvDaL1RK9gcrCcvy5BXQS7qFEH_da_fkxJoFdEW8HlDgt-OvBqnH2bGYfH_yz5BHtTs5Opmr64vTVId1wmWldYNJD2mk-rswjcK6meOyw9B2NxBsE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hVgIuBVoeS4H6gLhllYedxMeyzapAKRVLpb1FcexIqCJbdbMSy6k_ob-xv4TPTrKwBSSEuEWyx_JjxvN9znhM9BJOqVSJb4MYuPG4TgpPQk2wGQqAkSSS2uXSe38cH57yt1Mx7eKf7F2YNj_E6sDNWobbr62Bn-tq3chB6zwOF9odjXAhwyHw5CaPo9ASsYOPq1RSkeVB7eVIK8OnN6N6ftPSuqv6BX-uw1nnj8b36KwfSRuGcjZcNGpYfruR5PH_DPU-bXWwle23evaAbpl6m3b2a1D2L0v2irlAUndCv013Rv0jcjuUQw1Z1sxZY31iv0Ox9pUflk2y68urgLnrK8C87HOt22y2bFYxQFM2-jBFjZBBzQ1TS3Z0MkElBtuZlUtIPKTTcfZpdOh1bzp4pc1975WFLCroR8GNVqkSaVLqQCpfFjxIAqFTX6dh6SeApb40sYxMmsow0FUaaRPyJHpEG_WsNk-IwQbiWFTCgGXzKrRcPhZKcUhCKC4HFPTLl5-3qTvynygPZjS3M2of4hS5m9H864B2-3XOO2Oeo4KNhQUvG9DeqhTzaH-tFLWZLeZoDUAWfuPPNUDMQA4l2njcqs-PPgnsiSgdUOKU4K87m4-z1xP7-fSfJffo9snBOD96c_xul-66tLQuKukZbTQXC_McgKtRL5wlfQcTthmz
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Ets+transcription+factor+ESE%E2%80%901+mediates+induction+of+the+COX%E2%80%902+gene+by+LPS+in+monocytes&rft.jtitle=The+FEBS+journal&rft.au=Grall%2C+Franck+T.&rft.au=Prall%2C+Wolf+C.&rft.au=Wei%2C+Wanjiang&rft.au=Gu%2C+Xuesong&rft.date=2005-04-01&rft.issn=1742-464X&rft.eissn=1742-4658&rft.volume=272&rft.issue=7&rft.spage=1676&rft.epage=1687&rft_id=info:doi/10.1111%2Fj.1742-4658.2005.04592.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1742_4658_2005_04592_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-464X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-464X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-464X&client=summon